corporate funder

Knoa Pharma LLC

knoapharma.com (opens in a new tab)1 openCatalog updated

Open programs1

  1. Knoa Pharma Investigator-Initiated Research (IIR) Program — Opioid Overdose Reversal (nalmefene HCl)

    Knoa Pharma LLC offers investigator‑initiated research funding and collaborative support focused on opioid overdose reversal, with priority for studies examining clinical outcomes and resource use associated with nalmefene HCl injections (vial and Zurnai auto‑injector).

    Research ProjectHealth

    Deadline
    Not listed
    Amount
    Not listed

Program details are the catalog's own fields as FundFit holds them: title, category, deadline, and amount. For the full listing and eligibility, follow the funder's site.

Same type

More corporate funders

See FundFit match these programs to your researchers.

Request a demo

Or browse every funder in the directory →